Aller au contenu principal
Texte de la bannière

News and Events

Vibiosphen is proud to be part of a grooming ecosystem, we will be please to meet in these event


Participating to the BIO US 2023 conference

We are very proud to share that Vibiosphen will be participating to BIO US 2023 in Boston the first week of June.

We will be pleased to discover all the innovative projects in many fields.

Alternative technologies and models (NAMs) to Reduce the use of laboratory animals in Industry

Vibiosphen is attending and presenting at the Adebiotech event : Alternative technologies and models (NAMs) to Reduce the use of laboratory animals in Industry. 

Patricia Martin (CSO of Vibiosphen) will be presenting our model innovation in respiratory disease : the apical out lung organoids. 


Vibiosphen will be attending #ECCMID2023 in Copenhagen from 15th to 18th of April. We are excited to discover all the great science being done in the field of antimicrobials.

We will be pleased to talk about your project / science and to discuss how to push it one step forward in the preclinical space.

Organ Modelling Congress

Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug
development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool

6th AMR Conference

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.


Microbiome Movement Drug Development Europe

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Human - Animal One Health: At the Confluence of human & veterinary public health

Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both

AMR Innovation Mission Sweden 2022

The Mission aims to connect the Swedish AMR ecosystem to the international AMR ecosystem and vice versa.

Webinar : les membres AFSSI ont la parole

At the AFSSI webinar on May 25, 2021 at 3 p.m., Patricia Martin, CSO, will present Vibiosphen's innovative solutions.

Anti infectives drug development Webinar 21-22 April 2021

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater ...

Virtual AMR Innovation Mission UK 2021

The AMR Innovation Mission UK 2021 aims to add to the global curbing of Antimicrobial resistance (AMR) ...